BSX vs IRTC
BSX: Boston Scientific is a leading medical device company dedicated to transforming lives through innovative, less-invasive medical solutions for a broad range of interventional specialties. IRTC: iRhythm provides AI-powered, wearable ambulatory cardiac monitoring services that streamline the diagnosis of heart arrhythmias for clinicians.
Side-by-side fundamentals
| Metric | BSX | IRTC | Edge |
|---|---|---|---|
| Price as of 2026-08-21 close | $50.37 | $128.52 | |
| Market cap as of 2026-08-24 | $73.0B | $4.2B | |
| P/E as of 2026-08-24 | 20.40 | n/a | |
| PEG as of 2026-08-24 | 0.43 | n/a | |
| Net margin as of 2026-08-24 | +17.5% | -3.5% | BSX higher |
| Gross margin as of 2026-08-24 | +69.5% | +71.0% | IRTC higher |
| Operating margin as of 2026-08-24 | +19.8% | -5.2% | BSX higher |
| ROE as of 2026-08-24 | +14.9% | -20.6% | BSX higher |
| ROA as of 2026-08-24 | +8.3% | -2.8% | BSX higher |
| Debt / equity as of 2026-08-24 | 0.51 | 4.03 | BSX lower |
| Revenue growth (YoY) as of 2026-08-24 | +13.5% | +27.4% | IRTC higher |
| Revenue CAGR (3y) SEC XBRL | +16.5% | +22.1% | IRTC higher |
| Dividend yield | n/a | n/a | |
| Beta as of 2026-08-24 | 0.58 | 1.46 | |
| 1-year return as of 2026-08-21 close | -52.1% | -22.9% | IRTC higher |
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.